Guardant Health (GH) gets a favourable ruling from appeals court in patent case

Guardant Health's favorable ruling from the appeals court could significantly bolster its market position, particularly if the patent case involved key technologies.

Newsquawk StaffPublished On the live feed at 2 more headlines followed before this page went public
Newsquawk headlinesUTC

[MARKET UPDATE] Broad USD weakness continues, DXY hits new lows, GBP & AUD outperform; USD/JPY set to revisit earlier lows; newsflow remains light

European Closes: Euro Stoxx 50 -0.05% at 5,953, Dax 40 +0.01% at 24,859, FTSE 100 -0.07% at 10,143, CAC 40 -0.07% at 8,143, FTSE MIB -0.58% at 44,832, IBEX 35 -0.67% at 17,544, PSI -0.54% at 8,558, SMI -0.72% at 13,149, AEX -0.01% at 1,000

Guardant Health (GH) gets a favourable ruling from appeals court in patent case

OpenAI CEO Altman says a lot of exciting launches related to codex coming over the next month, starting next week

Michigan AG sues major oil companies, asserting they colluded to forestall competition from renewable energy, including EVs

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

This outcome may enhance investor confidence and could lead to increased interest or acquisitions in the biotech sector as companies assess the implications of patent protections in their own operations.

Related headlines

The whole workspace, free to try.

Try it free